{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:30:33Z","timestamp":1792596633978,"version":"4.5.0"},"reference-count":34,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Women who have gestational diabetes mellitus (GDM) have elevated lifetime risks for the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), compared with their peers. However, it is not known whether their risk of CVD is dependent upon the development of T2DM. Thus, we sought to evaluate the role of T2DM in determining vascular outcomes in women with previous GDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>All women in Ontario, Canada, with a live-birth pregnancy between April 1994 and March 2014 (n = 1,515,079) were stratified into the following four groups: women with GDM in whom T2DM subsequently developed (n = 15,585, median age 32 years); those with GDM in whom T2DM did not develop (n = 41,299; median age 32 years); women who did not have GDM but in whom T2DM developed (n = 49,397; median age 31 years); and those with neither GDM nor T2DM (n = 1,408,798; median age 30 years). Women were followed over a median time of 10.0 years for the development of microvascular and macrovascular outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among women who had GDM, only those in whom T2DM developed had an increased risk of vitrectomy\/photocoagulation (hazard ratio [HR] 4.49, 95% CI 3.90\u20135.17), renal dialysis (HR 7.52, 5.24\u201310.81), and hospitalization for foot infection (HR 4.32, 3.42\u20135.46) (all P &amp;lt; 0.0001). However, for macrovascular outcomes, both women with GDM in whom T2DM developed and those in whom T2DM did not develop had increased risks of CVD (HR 2.82; 2.41\u20133.30; P &amp;lt; 0.0001; and HR 1.30; 1.07\u20131.59; P = 0.008, respectively) and coronary artery disease (HR 3.54; 2.96\u20134.23; P &amp;lt; 0.0001; and HR 1.41; 1.11\u20131.80; P = 0.005, respectively), although absolute event rates were very low.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Women with GDM have an elevated risk of cardiovascular outcomes, even in the absence of T2DM. In contrast, microvascular risk emerges only in those in whom T2DM develops.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc16-1400","type":"journal-article","created":{"date-parts":[[2016,11,7]],"date-time":"2016-11-07T22:23:22Z","timestamp":1478557402000},"page":"101-108","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":151,"title":["Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus"],"prefix":"10.2337","volume":"40","author":[{"given":"Ravi","family":"Retnakaran","sequence":"first","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada"},{"name":"Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada"},{"name":"Division of Endocrinology, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiju R.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Toronto, Toronto, Canada"},{"name":"Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada"},{"name":"Institute for Clinical and Evaluative Sciences, Toronto, Canada"},{"name":"Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2022031301022303000_B1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"2022031301022303000_B2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157339909789804378","article-title":"Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women","volume":"5","author":"Retnakaran","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"2022031301022303000_B3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI200524531","article-title":"Gestational diabetes mellitus","volume":"115","author":"Buchanan","year":"2005","journal-title":"J Clin Invest"},{"key":"2022031301022303000_B4","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/dc10-0351","article-title":"Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy","volume":"33","author":"Retnakaran","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B5","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2337\/dc11-0817","article-title":"Hepatic insulin resistance is an early determinant of declining \u03b2-cell function in the first year postpartum after glucose intolerance in pregnancy","volume":"34","author":"Retnakaran","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B6","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2337\/db10-0521","article-title":"Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus","volume":"59","author":"Xiang","year":"2010","journal-title":"Diabetes"},{"key":"2022031301022303000_B7","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1007\/s00125-013-3048-0","article-title":"Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus","volume":"56","author":"Xiang","year":"2013","journal-title":"Diabetologia"},{"key":"2022031301022303000_B8","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.2337\/dc14-1529","article-title":"Each degree of glucose intolerance in pregnancy predicts distinct trajectories of \u03b2-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum","volume":"37","author":"Kramer","year":"2014","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pcd.2010.10.002","article-title":"Gestational diabetes mellitus: taking it to heart","volume":"5","author":"Marcinkevage","year":"2011","journal-title":"Prim Care Diabetes"},{"key":"2022031301022303000_B10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11892-011-0238-3","article-title":"Gestational diabetes: implications for cardiovascular health","volume":"12","author":"Sullivan","year":"2012","journal-title":"Curr Diab Rep"},{"key":"2022031301022303000_B11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jacc.2013.01.080","article-title":"Cardiometabolic consequences of gestational dysglycemia","volume":"62","author":"Brewster","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022031301022303000_B12","first-page":"e1","article-title":"Gestational diabetes and risk of cardiovascular disease: a scoping review","volume":"8","author":"Archambault","year":"2014","journal-title":"Open Med"},{"key":"2022031301022303000_B13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/WHE.13.69","article-title":"Gestational diabetes mellitus and cardiovascular risk after pregnancy","volume":"10","author":"Harreiter","year":"2014","journal-title":"Womens Health (Lond)"},{"key":"2022031301022303000_B14","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc05-2482","article-title":"Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes","volume":"29","author":"Carr","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc08-0706","article-title":"Increased risk of cardiovascular disease in young women following gestational diabetes mellitus","volume":"31","author":"Shah","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1503\/cmaj.090569","article-title":"Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a population-based cohort study","volume":"181","author":"Retnakaran","year":"2009","journal-title":"CMAJ"},{"key":"2022031301022303000_B17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/1471-0528.12754","article-title":"Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study","volume":"121","author":"Fadl","year":"2014","journal-title":"BJOG"},{"key":"2022031301022303000_B18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.25.3.512","article-title":"Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm","volume":"25","author":"Hux","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B19","first-page":"33","article-title":"Measuring \u201crurality\u201d for purposes of health-care planning: an empirical measure for Ontario","volume":"67","author":"Kralji","year":"2000","journal-title":"Ont Med Rev"},{"key":"2022031301022303000_B20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1471-0528.2011.03083.x","article-title":"Missed opportunities for type 2 diabetes testing following gestational diabetes: a population-based cohort study","volume":"118","author":"Shah","year":"2011","journal-title":"BJOG"},{"key":"2022031301022303000_B21","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc08-0972","article-title":"Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes","volume":"31","author":"Retnakaran","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B22","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1210\/jcem.87.7.8684","article-title":"Insulin resistance syndrome in women with prior history of gestational diabetes mellitus","volume":"87","author":"Verma","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301022303000_B23","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1210\/jc.2004-1713","article-title":"The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population","volume":"90","author":"Lauenborg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301022303000_B24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1210\/jc.2009-1990","article-title":"Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women","volume":"95","author":"Retnakaran","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301022303000_B25","doi-asserted-by":"crossref","first-page":"e87863","DOI":"10.1371\/journal.pone.0087863","article-title":"Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"2022031301022303000_B26","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2337\/dc11-0268","article-title":"Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study","volume":"34","author":"Tobias","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B27","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2337\/diacare.19.12.1351","article-title":"Lipid levels in former gestational diabetic mothers","volume":"19","author":"Meyers-Seifer","year":"1996","journal-title":"Diabetes Care"},{"key":"2022031301022303000_B28","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1210\/jc.2010-0361","article-title":"The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk","volume":"95","author":"Retnakaran","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031301022303000_B29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00125-009-1600-8","article-title":"Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia","volume":"53","author":"Retnakaran","year":"2010","journal-title":"Diabetologia"},{"key":"2022031301022303000_B30","doi-asserted-by":"crossref","first-page":"571","DOI":"10.33549\/physiolres.931073","article-title":"Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size","volume":"56","author":"Qiu","year":"2007","journal-title":"Physiol Res"},{"key":"2022031301022303000_B31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1464-5491.2008.02613.x","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes","volume":"25","author":"Rizzo","year":"2008","journal-title":"Diabet Med"},{"key":"2022031301022303000_B32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/aje\/kwq267","article-title":"Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus: the CARDIA study","volume":"172","author":"Gunderson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2022031301022303000_B33","doi-asserted-by":"crossref","first-page":"55.e1","DOI":"10.1016\/j.ajog.2011.03.037","article-title":"Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus","volume":"205","author":"Hedderson","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2022031301022303000_B34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mehy.2012.04.019","article-title":"Preeclampsia and gestational diabetes mellitus: pre-conception origins?","volume":"79","author":"Wen","year":"2012","journal-title":"Med Hypotheses"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/1\/101\/519487\/dc161400.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/40\/1\/101\/519487\/dc161400.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T23:37:37Z","timestamp":1647128257000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/40\/1\/101\/37108\/Role-of-Type-2-Diabetes-in-Determining-Retinal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,7]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2017,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc16-1400","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,7]]}}}